Nuzenio

Olomorasib

Olomorasib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 21 latest news signals 19 publisher sources 100/100 entity strength

Latest news

The OncFive: Top Oncology Articles for the Week of 8/2 - OncLiveOncLive · Sat, 08 Aug 2026 10:13:24 GMT FDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - Medical DailyMedical Daily · Thu, 06 Aug 2026 12:50:07 GMT FDA grants Lilly’s Olomorasib breakthrough therapy status in rare pancreatic cancer fight - Indian Pharma PostIndian Pharma Post · Wed, 05 Aug 2026 14:18:22 GMT FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 13:26:29 GMT Eli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Is The Stock Still Cheap? - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 05:13:10 GMT FDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -Pharmaceutical Business review - · Tue, 04 Aug 2026 19:15:28 GMT FDA Grants Breakthrough Therapy Status to Eli Lilly's Pancreatic Cancer Treatment - Investing News NetworkInvesting News Network · Tue, 04 Aug 2026 18:53:00 GMT Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMT

Timeline

Sat, 08 Aug 2026 10:13:24 GMTThe OncFive: Top Oncology Articles for the Week of 8/2 - OncLive

Thu, 06 Aug 2026 12:50:07 GMTFDA Grants Breakthrough Therapy Status to a Pancreatic Cancer Drug for a Mutation Found in Roughly 1 in 50 Patients - Medical Daily

Wed, 05 Aug 2026 14:18:22 GMTFDA grants Lilly’s Olomorasib breakthrough therapy status in rare pancreatic cancer fight - Indian Pharma Post

Wed, 05 Aug 2026 13:26:29 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - Oncodaily

Wed, 05 Aug 2026 05:13:10 GMTEli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Is The Stock Still Cheap? - Yahoo Finance

Tue, 04 Aug 2026 19:15:28 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Lilly16 live mentions Eli Lilly10 live mentions FDA8 live mentions KRAS8 live mentions LLY8 live mentions Wins FDA Breakthrough6 live mentions FDA Grants Breakthrough5 live mentions Amplia5 live mentions Tag For Olomorasib4 live mentions Therapy Status3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Olomorasib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

19 distinct publisher/source names are currently connected to this entity page.